Nuvalent
NUVL
NUVL was delisted on the 14th of July, 2026.
115 hedge funds and large institutions have $2.57B invested in Nuvalent in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 56 increasing their positions, 30 reducing their positions, and 10 closing their positions.
171% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $8.28M
87% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 30
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
10% more capital invested
Capital invested by funds: $2.33B → $2.57B (+$237M)
5% more funds holding
Funds holding: 110 → 115 (+5)
0.7% more ownership
Funds ownership: 107.54% → 108.24% (+0.7%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
+$23M |
| 2 |
PA
Perceptive Advisors
New York
|
+$11.9M |
| 3 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$11.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$9.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$35M |
| 2 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$19.2M |
| 3 |
CC
Commodore Capital
New York
|
-$14.3M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.94M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.99M |
NUVL Hedge Fund Activity: Q3 2023 in Review
115 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q3 2023, worth a combined $2.57B — up 10% from $2.33B a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NUVL positions and 10 closed out — a net gain of 5 holders — while 56 added to existing stakes and 30 trimmed.
The largest buyer was Paradigm Biocapital Advisors, adding an estimated $23M. The largest seller was Avoro Capital Advisors, cutting an estimated $35M.
- 115 institutional investors held Nuvalent (NUVL) as of Q3 2023, up from 110 in Q2 2023.
- Funds reported $2.57B of Nuvalent stock for Q3 2023, up 10% quarter-over-quarter.
- 15 funds opened new Nuvalent positions in Q3 2023 and 10 closed out, a net change of +5 holders.
- The largest Nuvalent buyer in Q3 2023 was Paradigm Biocapital Advisors, an estimated $23M added.
- The largest Nuvalent seller in Q3 2023 was Avoro Capital Advisors, an estimated $35M sold.
Based on aggregated 13F filings for Q3 2023.